Grace Water Med Public Company Limited (GWM25) made its trading debut on the LiVEx Exchange on Friday, September 19, 2025, attracting keen investor interest. The company was supported in the listing process by Zenon Advisory Limited, serving as its financial advisor.
Mr. Thongchai Pami, Chief Executive Officer of GWM25, said the positive market reception reflects strong investor confidence in the company’s growth potential. He projected 2025 revenue of no less than THB 180 million, with an average annual growth rate of at least 10%, and announced the company’s plan to list on the Market for Alternative Investment (mai) within the next three years to attract more institutional investors both domestically and internationally.
Proceeds from the fundraising will be allocated to expanding the company’s dialysis center and reverse osmosis (RO) water system business, repaying debt, and supporting working capital. With Thailand entering an aging society, the number of kidney disease patients continues to rise, while government subsidies of THB 1,500 per dialysis session – totaling over THB 20 billion last year – further support the sector’s long-term growth.
GWM25 operates an integrated kidney care business, including the production and distribution of dialysis solutions and disinfectants, sales and rental of medical supplies, design and maintenance of RO water systems, and kidney-related supplements and cosmeceuticals. This comprehensive approach underscores the company’s commitment to enhancing patients’ quality of life while positioning itself for sustainable growth.
Source: https://today.line.me/th/v3/article/zNkx9gg
https://www.prachachat.net/finance/news-1887597
https://hoonsmart.com/archives/378108
